SCHEMBL3472734

SCHEMBL3472734

CN(C)P(=O)(c1ccccc1)N(C)C

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.48
HTT P42858 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CA2 P00918 1/20 0.46
CA4 P22748 1/20 0.46
CA5A P35218 1/20 0.46
ESR1 P03372 1/20 0.43
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
CFTR P13569 1/20 0.41
USP2 O75604 1/20 0.40
TDP1 Q9NUW8 1/20 0.39
GAA P10253 1/20 0.39
ALPG P10696 1/20 0.39
ALOX12 P18054 1/20 0.39
NPY1R P25929 1/20 0.39
NPY2R P49146 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
TSHR P16473 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525867 0.79 MAPT (0.48) MAPTHTTMEN1KMT2ACA2
SCHEMBL13043275 0.78 KMT2A (0.67) MAPTHTTMEN1KMT2ACA2
SCHEMBL13059485 0.75 KDM4E (0.31) HTTMEN1KMT2AALDH1A1GAA
SCHEMBL18855068 0.75 ALDH1A1 (0.56) MAPTMEN1KMT2AALDH1A1TDP1
SCHEMBL7869187 0.75 ACHE (0.36) TDP1
SCHEMBL27823915 0.75 MAPT (0.45) MAPTHTTMEN1KMT2ACA2
SCHEMBL10965668 0.73 TSHR (0.32) MAPTHTTMEN1KMT2ATSHR
SCHEMBL17377380 0.73 L3MBTL1 (0.47) MAPTHTTMEN1KMT2ACA2
SCHEMBL12150822 0.72 HTT (0.46) MAPTHTTMEN1KMT2ACA2
SCHEMBL3988655 0.72 CA2 (0.39) MAPTHTTMEN1KMT2ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2212684-B1 A METHOD OF MONITORING SURFACE ASSOCIATED MICROBIOLOGICAL ACTIVITY IN PROCESS STREAMS NALCO CO (US) 2021-12-22 EP claimed
EP-3258262-B1 A METHOD OF MONITORING BULK MICROBIOLOGICAL ACTIVITY IN PROCESS STREAM NALCO CO (US) 2019-08-28 EP claimed
EP-2212687-B1 A METHOD OF MONITORING BULK (TOTAL) MICROBIOLOGICAL ACTIVITY IN PROCESS STREAMS NALCO CO (US) 2017-07-19 EP claimed
CN-102942775-A Polycarbonate with reduced color SABIC INNOVATIVE PLASTICS IP 2013-02-27 CN claimed
CN-101484530-B Polycarbonate with reduced color SABIC INNOVATIVE PLASTICS IP 2013-01-02 CN claimed
US-7645851-B2 Polycarbonate with reduced color SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2010-01-12 US claimed
CN-101484530-A Polycarbonate with reduced color SABIC INNOVATIVE PLASTICS IP (NL) 2009-07-15 CN claimed
EP-2035500-A2 POLYCARBONATE WITH REDUCED COLOR Sabic Innovative Plastics IP B.V. (NL) 2009-03-18 EP claimed
WO-2008005655-A2 POLYCARBONATE WITH REDUCED COLOR SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-01-10 WO claimed
US-20080004379-A1 Polycarbonate with Reduced Color GENERAL ELECTRIC COMPANY (US) 2008-01-03 US claimed
EP-0119560-A2 Hypohalite-based bleaching, cleaning and disinfecting agent with storing stability B. Braun-SSC AG (CH) 1984-09-26 EP claimed
US-4079103-A Process for the production of phosphite chlorides CIBA-GEIGY CORPORATION (US) 1978-03-14 US claimed
US-12552762-B2 Fluorolactone and method for producing same DAIKIN INDUSTRIES, LTD. (JP) 2026-02-17 US disclosed
CN-113825747-B Fluorolactones and process for producing the same 大金工业株式会社 2025-04-25 CN disclosed
US-20240327373-A1 FLUOROLACTONE AND METHOD FOR PRODUCING SAME DAIKIN INDUSTRIES, LTD. (JP) 2024-10-03 US disclosed
CN-118440045-A Fluorolactones and process for producing the same 大金工业株式会社 2024-08-06 CN disclosed
WO-2008005655-A2 POLYCARBONATE WITH REDUCED COLOR SABIC INNOVATIVE PLASTICS IP B.V. (NL) 2008-01-10 WO disclosed
US-20080004379-A1 Polycarbonate with Reduced Color GENERAL ELECTRIC COMPANY (US) 2008-01-03 US disclosed
EP-0119560-A2 Hypohalite-based bleaching, cleaning and disinfecting agent with storing stability B. Braun-SSC AG (CH) 1984-09-26 EP disclosed
US-4079103-A Process for the production of phosphite chlorides CIBA-GEIGY CORPORATION (US) 1978-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240327373-A1 FLUOROLACTONE AND METHOD FOR PRODUCING SAME AFF1, AFF4, AFF2 MAPT 3791/4885HTT 1659/4885MEN1 39/4885
US-12552762-B2 Fluorolactone and method for producing same AFF1, FLNA, AFF2 MAPT 3325/4885HTT 2491/4885MEN1 98/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.